Sotera Health : Barclays Adjusts Sotera Health's Price Target to $29 From $35, Maintains Overweight Rating
© MT Newswires 2021
All news about SOTERA HEALTH COMPANY |
|
|
|
Analyst Recommendations on SOTERA HEALTH COMPANY |
|
|
| |
|
Sales 2022 |
1 018 M
-
-
|
Net income 2022 |
174 M
-
-
|
Net Debt 2022 |
1 401 M
-
-
|
P/E ratio 2022 |
31,4x |
Yield 2022 |
- |
|
Capitalization |
5 529 M
5 529 M
-
|
EV / Sales 2022 |
6,81x |
EV / Sales 2023 |
6,08x |
Nbr of Employees |
3 000 |
Free-Float |
96,0% |
|
Chart SOTERA HEALTH COMPANY
Duration :
Period :
|

Technical analysis trends SOTERA HEALTH COMPANY
| Short Term | Mid-Term | Long Term | Trends | Bearish | Neutral | Bearish |
Income Statement Evolution
|
Mean consensus |
OUTPERFORM |
Number of Analysts |
8 |
Last Close Price |
19,55 $ |
Average target price |
27,50 $ |
Spread / Average Target |
40,7% |
|